News
Faces of Future: Dr. Ingmar Schuster
Ingmar Schuster, scientist, co-founder, and CEO of Exazyme, pioneers AI-driven protein development at Freie Universität Berlin’s Startup Villa. He unveils how Exazyme was born from talks with Thomas Happe’s research team, evolving into a business idea. Schuster sees Exazyme revolutionizing industries reliant on chemical reactions and enzymes, enhancing sustainability and efficiency. He discusses the hurdles for German scientist-entrepreneurs, advocating for a shift in investor attitudes and administrative processes to nurture scientific entrepreneurship.
Read full article here: https://zukunftsorte.berlin/faces-of-future/ingmar-schuster/
ZUKUNFTSORTE BERLIN, 24th October 2022
More from Exazyme
- Success Story/
Max-Planck Institute
Discover how Exazyme’s machine learning solutions dramatically improved the performance of the GCC enzyme, increasing carbon fixation rates by 2.8 times and reducing energy demand by 60%.
Read More
- News/
Exazyme partners with Ginkgo Bioworks and becomes part of the Ginkgo Technology Network
Exazyme partners with Ginkgo Bioworks, joining the Ginkgo Technology Network to empower R&D teams with AI-driven protein engineering solutions.
Read More